Evidence map›Paper›PMID 20237485›Full record

Trial reportJournal of perinatology : official journal of the California Perinatal Association2010

High-flow nasal cannula and extubation success in the premature infant: a comparison of two modalities.

S M Miller, S A Dowd

Abstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of perinatology : official journal of the California Perinatal Association, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. High flow nasal cannula for respiratory support in preterm infants.The Cochrane database of systematic reviews · 2016
    Pooled it
  2. Nasal high flow therapy for primary respiratory support in preterm infants.The Cochrane database of systematic reviews · 2023
    Review
  3. Nasal high flow treatment in preterm infants.Maternal health, neonatology and perinatology · 2017
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. CPAP review.European journal of pediatrics · 2012
    Review
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S M MillerDivision of Newborn Medicine, Weill Cornell Medical College, New York, NY, USA.
S A Dowd

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the effectiveness of Fisher and Paykel (FP) and Vapotherm (VT) high-flow nasal cannula (HFNC) in preventing reintubation either within 72 h or <7 days after extubation of premature infants. The primary outcome was the rate of extubation failure defined as reintubation within 72 h. Secondary outcomes included reintubation after ≤7 days. STUDY

designThis was a prospective, randomized pilot study comparing the extubation success of 40 infants born between 26 and 29 weeks of gestation.

resultThe rate of extubation failure at 72 h was 18% for FP and 9% for VT. The failure rate ≤7 days after extubation was 30% for FP and 27% for VT. None of these differences were statistically significant.

conclusionThere was no difference between FP and VT in the extubation success of infants born between 26 and 29 weeks.

Indexed as

Infant, Extremely Low Birth WeightInfant, Very Low Birth WeightVentilator WeaningCarbon DioxideContinuous Positive Airway PressureEquipment DesignFemaleHigh-Frequency VentilationHumansInfant, NewbornIntubation, IntratrachealMaleOxygenPilot ProjectsProspective StudiesRespiratory Distress Syndrome, NewbornCarbon DioxideOxygen

Identifiers

PMID20237485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.